Results 11 to 20 of about 1,359,740 (203)

Resurrecting Epstein–Barr Virus

Pathogens, 2022
One of the Editor’s choice articles in 2021 published in Pathogens was an early assessment of the role of Epstein–Barr virus (EBV) reactivation in the pathogenesis of long-term symptoms associated with COVID-19 [...]
Roberto Paganelli
doaj   +4 more sources

Das Epstein-Barr-Virus ( = Epstein-Barr virus) [PDF]

, 1993
Epstein-Barr virus is an ubiquitous humanpathogenic herpesvirus. It has been identified as the etiologic agent of infectious mononucleosis. In addition it is associated with the cancers nasopharyngeal carcinoma and Burkitt's lymphoma. Like other herpesviruses it infects cells in a lytic way or it persists in a latent state.
Niller, H. H., Wolf, Hans J.
core   +4 more sources

EPSTEIN-BARR VIRUS VACCINES [PDF]

Clinical & Translational Immunology, 2015
Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis (IM) and is associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric carcinoma, as well as lymphoid malignancies including Hodgkin lymphoma, Burkitt lymphoma, non‐Hodgkin lymphoma and post‐transplant lymphoproliferative disorder.
KANEKIYO MASARU, NABEL GARY J, COHEN JEFFREY, BU WEI   +3 more
openaire   +10 more sources

Epstein-Barr Virus

Microbiology Spectrum, 2016
ABSTRACT This review covers relevant clinical and laboratory information relating to Epstein-Barr virus (EBV) infections in immunocompromised hosts. It describes the epidemiology and clinical manifestations with a primary focus on disease in solid organ and stem cell transplant recipients.
Andrew, Nowalk, Michael, Green
openaire   +2 more sources

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. [PDF]

, 2007
Epstein-Barr virus (EBV) is associated with a number of human malignancies. EBV-positive post-transplant lymphoproliferative disease in solid organ and hematopoietic stem cell transplant recipients has been successfully treated by the adoptive transfer ...
Burdach, S., Witter, K., Boerschmann Heike, Boerschmann, H., Mautner, Josef, Georg W Bornkamm, Adhikary, D., Adhikary, Dinesh, Uta Behrends, Burdach Stefan, Bornkamm, G.W., Mautner, J., Georg W, Andrea Pfünder, Moosmann, A., Witter Klaus, Adhikary Dinesh, Pfünder, Andrea, Dinesh Adhikary, Klaus Witter, Pfünder Andrea, Josef Mautner, Behrends Uta, Stefan Burdach, Moosmann Andreas, Andreas Moosmann, Bornkamm Georg W., Behrends, Uta, Boerschmann, Heike, Burdach, Stefan, Bornkamm, Georg W., Pfünder, A., Witter, Klaus, Behrends, U., Mautner Josef, Moosmann, Andreas, Heike Boerschmann, Adhikary, D;Behrends, U;Boerschmann, H;Pfünder, A;Burdach, S;Moosmann, A;Witter, K;Bornkamm, GW;Mautner, J, Georg W. Bornkamm   +38 more
core   +1 more source

Epstein-Barr Virus LF2: an Antagonist to Type 1 Interferon [PDF]

, 2009
Upon viral infection, the major defense mounted by the host immune system is activation of the interferon (IFN)-mediated antiviral pathway, which is mediated by IFN regulatory factors (IRFs).
Shin, Young Chul, Johannsen, Eric, Haas, Juergen, Hyun Joo, Chul, Fossum, Even, Hutt-Fletcher, Lindsay M., Wu, L., Inn, Kyung-Soo, Jung, Jae U.   +8 more
core   +1 more source

Epstein-Barr Virus and the Eye [PDF]

Ocular Immunology and Inflammation, 2020
Epstein-Barr Virus (EBV), also known as Human HerpesVirus-4 (HHV-4), is a γ-type herpesvirus with a global infection prevalence of over 95%.1,2 Infection, which occurs nasopharyngeally via either a...
Emmett T, Cunningham, Manfred, Zierhut
openaire   +2 more sources

Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. [PDF]

, 2010
BACKGROUND: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are persistent herpesviruses that have various immunomodulatory effects on their hosts. Both viruses are usually acquired in infancy in Sub-Saharan Africa, a region where childhood vaccines ...
Ebrima S Touray, Whittle, H., Miles David J. C., Kaye, Steve, Melba S Palmero, Roberts, E., Ojuola, Olubukola, Palmero Melba S., Ojuola, O, Kaye Steve, Duah, NO, Mohammed, N.I., Cotten, M., Marianne van der Sande, Waight Pauline, Rowland-Jones, S., Cotten, M, Touay, Ebrima S., Holder, B., Cotten Matthew, Mohammed, NI, van der Sande Marianne, Whittle, H, Crozier, Sarah, Roberts, Elishia, Rowland-Jones, Sarah, Crozier, S., Miles, David J.C., Palmero, Melba S., Ojuola Olubukola, Waight, P., Touray, ES, Beth Holder, Roberts Elishia, Nuredin Ibrahim Mohammed, Nancy O Duah, Sarah Crozier, Touray, E.S., Hilton Whittle, Mohammed, Nuredin Ibrahim, Elishia Roberts, Sarah Rowland-Jones, Ebrima S. Touray, Touray, Ebrima S, van der Sande, M., Nancy O. Duah, Matthew Cotten, Whittle Hilton, Miles, David J C, Steve Kaye, Miles, David JC, van der Sande, Marianne, Kaye, S, Ojuola, O., David J C Miles, Mohammed Nuredin Ibrahim, Holder Beth, Palmero, M.S., Duah Nancy O., Melba S. Palmero, Cotten, Matthew, Duah, Nancy O, Palmero, Melba S, Whittle, Hilton, Miles, DJC, Rowland-Jones Sarah, Miles, D.J., Kaye, S., Holder, B, Olubukola Ojuola, David J. C. Miles, Touray Ebrima S., Duah, Nancy O., Palmero, MS, Duah, N.O., Waight, Pauline, Roberts, E, Rowland-Jones, S, Holder, Beth, Waight, P, Crozier, S, Pauline Waight, Crozier Sarah, Van der Sande, M   +83 more
core   +1 more source

Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus [PDF]

, 2010
Background. Non-coding RNAs have critical functions in diverse biological processes, particularly in gene regulation. Viruses, like their host cells, employ such functional RNAs and the human cancer associated Epstein-Barr virus (EBV) is no exception ...
Tsimbouri Penelope M., Philbey, A.W., Philbey, Adrian W, Repellin, C.E, Claire E Repellin, Wilson, J.B., Joanna B Wilson, Repellin, Claire E, Tsimbouri, P.M., Wilson Joanna B., Philbey Adrian W., Tsimbouri, Penelope M, Adrian W Philbey, Penelope M Tsimbouri, Wilson, Joanna B, Repellin Claire E.   +15 more
core   +2 more sources

Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition [PDF]

, 2010
Background Epstein-Barr virus (EBV)-encoded LMP1 protein is commonly expressed in nasopharyngeal carcinoma (NPC). LMP1 is a prime candidate for driving tumourigenesis given its ability to activate multiple signalling pathways and to alter the expression
Yanxing Yu, Lawrence S Young, Lo, KW, Dawson, Christopher W., Kwok W Lo, Lo, Angela, Angela KF Lo, Lo, Kwok W., Dawson, Christopher, Young, Lawrence, Yu, Yanxing, Lo, Angela K. F., Young, Lawrence S., Yu, Y, Christopher W Dawson, Young Lawrence S, Yu Yanxing, Lo Kwok W, Lo Angela KF, Dawson Christopher W   +19 more
core   +1 more source